Oncotargets And Therapy

Oncotargets And Therapy英文簡介

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.

The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype.

Specific topics covered by the journal include:

-Novel therapeutic targets and innovative agents

-Novel therapeutic regimens for improved benefit and/or decreased side effects

-Early stage clinical trials

Further considerations when submitting to OncoTargets and Therapy:

-Studies containing in vivo animal model data will be considered favorably.

-Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines.

-Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples.

-Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Single nucleotide polymorphism (SNP) studies will not be considered.

Oncotargets And Therapy中文簡介

《Oncotargets And Therapy》是一本由DOVE MEDICAL PRESS LTD出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2008年，刊期1 issue/year，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 4區(qū)，小類學(xué)科：生物工程與應(yīng)用微生物 3區(qū)；腫瘤學(xué) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q2。該刊發(fā)文范圍涵蓋生物工程與應(yīng)用微生物等領(lǐng)域，旨在及時、準確、全面地報道國內(nèi)外生物工程與應(yīng)用微生物工作者在該領(lǐng)域取得的最新研究成果、工作進展及學(xué)術(shù)動態(tài)、技術(shù)革新等，促進學(xué)術(shù)交流，鼓勵學(xué)術(shù)創(chuàng)新。2021年影響因子為4.345，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ONCOLOGY 腫瘤學(xué)	3區(qū) 4區(qū)	否	否

中科院分區(qū)最新基礎(chǔ)版（當前數(shù)據(jù)版本：2021年12月最新基礎(chǔ)版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	3區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)	否	否

中科院JCR分區(qū)歷年趨勢圖

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學(xué)科	分區(qū)	影響因子
Q2	ONCOLOGY	Q2	4.345
	BIOTECHNOLOGY & APPLIED MICROBIOLOGY	Q2

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
4.345	44	97.03%	84.15%	開放	較慢,6-12周

IF值(影響因子)趨勢圖